Nothing Special   »   [go: up one dir, main page]

Xia et al., 2006 - Google Patents

Targeted Disruption of the Gene Encoding Core 1 β1‐3‐Galactosyltransferase (T‐Synthase) Causes Embryonic Lethality and Defective Angiogenesis in Mice

Xia et al., 2006

Document ID
1945607780748639385
Author
Xia L
McEver R
Publication year
Publication venue
Methods in enzymology

External Links

Snippet

The biosynthesis of the core 1 O‐glycan (Galβ1‐3GalNAcα1‐Ser/Thr, T antigen) is controlled by core 1 β1–3‐galactosyltransferase (T‐synthase), which catalyzes the addition of Gal to GalNAcα1‐Ser/Thr (Tn antigen). The T antigen is a precursor for extended and …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes

Similar Documents

Publication Publication Date Title
Xia et al. Defective angiogenesis and fatal embryonic hemorrhage in mice lacking core 1–derived O-glycans
Wang et al. Modeling human congenital disorder of glycosylation type IIa in the mouse: conservation of asparagine-linked glycan-dependent functions in mammalian physiology and insights into disease pathogenesis
Tenno et al. Initiation of protein O glycosylation by the polypeptide GalNAcT-1 in vascular biology and humoral immunity
Ensslin et al. Identification of mouse sperm SED1, a bimotif EGF repeat and discoidin-domain protein involved in sperm-egg binding
Smith et al. Conditional control of selectin ligand expression and global fucosylation events in mice with a targeted mutation at the FX locus
HajMohammadi et al. Normal levels of anticoagulant heparan sulfate are not essential for normal hemostasis
Wang et al. A novel aminophospholipid transporter exclusively expressed in spermatozoa is required for membrane lipid asymmetry and normal fertilization
Jeyakanthan et al. Chemical basis for qualitative and quantitative differences between ABO blood groups and subgroups: implications for organ transplantation
Williams et al. Fertilization in mouse does not require terminal galactose or N-acetylglucosamine on the zona pellucida glycans
Xia et al. Targeted Disruption of the Gene Encoding Core 1 β1‐3‐Galactosyltransferase (T‐Synthase) Causes Embryonic Lethality and Defective Angiogenesis in Mice
Weinhold et al. Deficits in sialylation impair podocyte maturation
Ito et al. Glycoprotein hyposialylation gives rise to a nephrotic-like syndrome that is prevented by sialic acid administration in GNE V572L point-mutant mice
Hellbusch et al. Golgi GDP-fucose transporter-deficient mice mimic congenital disorder of glycosylation IIc/leukocyte adhesion deficiency II
Ma et al. Slc35a1 deficiency causes thrombocytopenia due to impaired megakaryocytopoiesis and excessive platelet clearance in the liver
Rodeheffer et al. Targeted mutations in β1, 4-galactosyltransferase I reveal its multiple cellular functions
US6376475B1 (en) Control of immune responses by modulating activity of glycosyltransferases
Pan et al. Heparan sulfate expression in the neural crest is essential for mouse cardiogenesis
Wang et al. Mice with a homozygous deletion of the Mgat2 gene encoding UDP-N-acetylglucosamine: α-6-D-mannoside β1, 2-N-acetylglucosaminyltransferase II: A model for congenital disorder of glycosylation type IIa
Shur Reassessing the role of protein-carbohydrate complementarity during sperm-egg interactions in the mouse
US7674577B2 (en) Diagnosis of human glycosylation disorders
Fukuda et al. In vivo role of α-mannosidase IIx: ineffective spermatogenesis resulting from targeted disruption of the Man2a2 in the mouse
US7192914B1 (en) Prevention of atherosclerosis and undesired blood clotting by reducing von Willebrand factor
JP2002530425A (en) Use of a core 2GlcNAc transferase inhibitor in treating inflammation
Chen et al. Abnormalities caused by carbohydrate alterations in Iβ6-N-acetylglucosaminyltransferase-deficient mice
XIA et al. 314 FUNCTIONS REVEALED BY FORCED EXPRESSION OR GENE KNOCKOUT [21]